COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?

J Glob Health. 2022 Aug 3:12:03055. doi: 10.7189/jogh.12.03055.

Oluwatosin Wuraola Akande^{1

2}, Ehimario Uche Igumbor^{1

2

3}, Kelly Osezele Elimian^{1

2

4}, Cornelius Ehizokhai Ohonsi^{1

2}, Lilian Nwozor^{1

2}, Okanke Oden^{1

2}, Emmanuel Nsa Ekpenyong², Nnaemeka Ndodo¹, Ifeanyi F Ike^{1

5}, Magdalene Egede^{1

2}, William Nwachukwu^{1

2}, Amedu M Onoja^{1

2}, Jenson Gawain Fofah^{2

6}, Reuben Ishiaku Azi¹, Chinwe L Ochu^{1

2}, Ifedayo M Adetifa^{1

7}

¹ Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
² Nigeria COVID-19 Research Coalition (NCRC), Abuja, Nigeria.
³ School of Public Health, University of the Western Cape, Cape Town, South Africa.
⁴ Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
⁵ International Society for Infectious Diseases, Massachusetts, USA.
⁶ Federal Ministry of Health, Abuja, Nigeria.
⁷ London School of Hygiene and Tropical Medicine, London, UK.

No abstract available

MeSH terms